vTv Therapeutics Inc. (VTVT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    vTv Therapeutics Inc.

    NASDAQ: VTVT · Real-Time Price · USD
    22.01
    -0.80 (-3.50%)
    At close: Sep 26, 2025, 12:21 PM

    vTv Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1.02M n/a 2.02M 4M
    Cost of Revenue
    		 89K 90K 92K 89K
    Gross Profit
    		 928K -90K 1.93M 3.92M
    Operating Income
    		 -24.18M -25.5M -22.54M -21.66M
    Interest Income
    		 1.56M 472K 352K 1K
    Pretax Income
    		 -22.61M -25.97M -24.87M -17.62M
    Net Income
    		 -18.46M -20.25M -19.16M -12.99M
    Selling & General & Admin
    		 13.65M 11.91M 12.2M 12.34M
    Research & Development
    		 11.55M 13.51M 12.36M 13.32M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 25.2M 25.41M 24.56M 25.67M
    Interest Expense
    		 n/a 13K 15K 12K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 25.2M 25.5M 24.56M 25.67M
    Income Tax Expense
    		 100K n/a 200K 115K
    Shares Outstanding (Basic)
    		 5.77M 2.08M 1.92M 1.57M
    Shares Outstanding (Diluted)
    		 5.77M 2.08M 1.92M 1.57M
    EPS (Basic)
    		 -3.2 -9.71 -9.98 -8.29
    EPS (Diluted)
    		 -3.2 -9.71 -9.98 -8.29
    EBITDA
    		 -22.52M -25.86M -24.77M -17.52M
    EBIT
    		 -22.61M -25.95M -24.86M -17.6M
    Depreciation & Amortization
    		 89K 90K 92K 89K

    Add to Watchlist